14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026
CCD vs THW: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 16, 2026, abrdn World Healthcare Fund (THW) captures the overall head-to-head institutional edge over Calamos Dynamic Convertible & Income Fund (CCD) on higher Unified Composite conviction (36.7/100 SELL vs. 40.6/100 SELL) after splitting the core matrix 2–2 (led by composite factor balance), while CCD wins 1–0 across the 6-pillar growth and valuation breakdown. CCD trades at $19.31 (N/M Forward P/E, N/A operating margin) versus THW at $12.91 (N/M Forward P/E, N/A operating margin).
Composite vs. Pillar Nuance: While CCD currently prints a higher short-term Unified Composite Score (40.6/100 SELL vs. THW 36.7/100 SELL), THW captures the overall institutional head-to-head verdict (2–2 matrix metrics and 0–1 across the 6 pillars) due to superior fundamental profitability (N/A vs. N/A operating margin) and revenue trajectory (N/A vs. N/A YoY).
Defensive Composite Rating Caution: Although THW compares more favorably head-to-head, both CCD (40.6/100 SELL) and THW (36.7/100 SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model.
Technical & Structure Timing Caution: CCD is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 28.8); meanwhile THW is in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 49.4). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on CCD vs THW. Trailing 12-month operating profitability (CCD N/A vs THW N/A) and valuation multiples (CCD N/M vs THW N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Institutional Equity value chain with $510.6M market capitalization and N/A operating margin.
OpEx & R&D ReinvestmentN/A
90D Engineering Disclosures0 Published
Investor FAQ CCD vs THW Key Questions & Quantitative Answers
As of Nov 16, 2026, abrdn World Healthcare Fund (THW) captures the overall head-to-head institutional edge over Calamos Dynamic Convertible & Income Fund (CCD) on higher Unified Composite conviction (36.7/100 SELL vs. 40.6/100 SELL) after splitting the core matrix 2–2 (led by composite factor balance), while CCD wins 1–0 across the 6-pillar growth and valuation breakdown. CCD trades at $19.31 (N/M Forward P/E, N/A operating margin) versus THW at $12.91 (N/M Forward P/E, N/A operating margin). Composite vs. Pillar Nuance: While CCD currently prints a higher short-term Unified Composite Score (40.6/100 SELL vs. THW 36.7/100 SELL), THW captures the overall institutional head-to-head verdict (2–2 matrix metrics and 0–1 across the 6 pillars) due to superior fundamental profitability (N/A vs. N/A operating margin) and revenue trajectory (N/A vs. N/A YoY). Defensive Composite Rating Caution: Although THW compares more favorably head-to-head, both CCD (40.6/100 SELL) and THW (36.7/100 SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model. Technical & Structure Timing Caution: CCD is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 28.8); meanwhile THW is in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 49.4). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
CCD leads the Growth & Scale pillar: CCD posts N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin), compared with THW at N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin). On trailing 12-month operating scale, CCD generates N/A in USD-normalized revenue versus N/A for THW. In operating R&D and SG&A reinvestment, CCD deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for THW.
CCD and THW trade at balanced relative valuation multiples. CCD trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin), whereas THW trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against CCD (N/A ROE) versus THW (N/A ROE) capital efficiency.
In options market volatility and institutional positioning, CCD carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.31β · 30% Vol realized risk). By comparison, THW carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.71β · 27% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.